Summary

for people ages 13-15 (full criteria)
at San Francisco, California
study started
estimated completion
Mehrdad Arjomandi

Description

Summary

The BREATHE (Behavioral Research of Environment and Air Pollution Through Education) study is a pilot randomized control trial comparing the efficacy of a classroom-based intervention to no intervention in helping middle-school students understand and make behavioral decisions about air pollution. This study is designed to evaluate the effectiveness of the classroom-based intervention on knowledge of air pollution, understanding of air pollution sources, and behavioral choices made to reduce both contributions to air pollution and personal exposure to air pollution. It has been well established that pollution is a racial and economic issue. Low-income areas with populations of predominantly people of color tend to be those with the highest rates of pollution and the largest particulate exposure. Creation of and exposure to this pollution is a key issue for the health of inhabitants of these areas, and of those in the broader surrounding areas. By developing, and assessing the effectiveness of, the investigators hope that the BREATHE study will give the investigators insights into how to better combat this higher exposure and reduce the health risks for those in high pollution areas. The study will take place in 4 visits over a period of 12 months. The hypothesis is that the classroom-based intervention will be effective in leading to behaviors that will reduce exposure to air pollution.

Official Title

Behavioral Research of Environment and Air Pollution Through Education (BREATHE Study)

Keywords

Attitude to HealthPollution Related Respiratory DisorderHealth BehaviorRespiration DisordersRespiratory Tract DiseasesAir Pollution EducationNon-Air Pollution Education

Eligibility

You can join if…

Open to people ages 13-15

  • Ability to read, write, and understand English at a middle school level
  • Willing to participate in follow up visits

You CAN'T join if...

  • Learning disabilities such as autism
  • Moving out of the area in the next 6 months
  • Inability to complete the questionnaires

Location

  • University of California San Francisco
    San FranciscoCalifornia94143United States

Lead Scientist

  • Mehrdad Arjomandi
    Dr. Arjomandi is Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy, Immunology, and Sleep Medicine at UCSF with a joint appointment at San Francisco Veterans Affairs Medical Center.

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT02471872
Study Type
Interventional
Last Updated